InsidersTradesSigma
카이노스메드 Stock: price and insider trades · South Korea · DART (FSS)
Track the 카이노스메드 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 카이노스메드 has recorded 1 public disclosures. Market capitalisation: €35.6bn. The latest transaction was reported on 17 March 2026 (Other). Among the most active insiders: 카이노스메드. The full history is accessible without an account.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 27,289 of 28,017 companies
11.3
score / 100
Value11
Quality12
FCF yld-17%
Earn yld-22%
EV/EBITDA·
ROE-91%
Gross mgn17%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 17 March 2026
About 카이노스메드
Kainosmed operates in the healthcare and pharmaceutical sector, listed on the XKRX market. The company focuses on developing innovative solutions for the medical field.